Search

Search Constraints

You searched for: Is Part Of Cancer. Volume 120:Issue 13(2014)

Search Results

1. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014)

2. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014)

3. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts. Issue 13 (15th April 2014)

4. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts. Issue 13 (15th April 2014)

7. Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network. Issue 13 (4th April 2014)

8. Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network. Issue 13 (4th April 2014)

9. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer. Issue 13 (26th March 2014)

10. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer. Issue 13 (26th March 2014)